Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.

Fragoso Y D, Alves-Leon S V, Becker J, Brooks J B B, Correa E C, Damasceno A, da Gama P D, da Gama R A, da Matta A P C, Maciel E P, et al.